Developer docs
API playgroundTry for free, no card

Search company profiles

SpeciCare

Full company profile

uuid0003hfz

Namestring
SpeciCare
Legal namestring
SpeciCare
Websiteurl
specicare.com
Company typeenum
Private
Founded yearint
2015
Descriptiontext

SpeciCare is a privately held US healthcare services company founded in 2015 and headquartered in Gainesville, Georgia, that cryopreserves live tumor tissue at ultra-low temperatures (-196°C in liquid nitrogen) and offers a suite of advanced cancer testing services built on the preserved tissue. The company serves three customer segments: individual cancer patients acquired direct-to-consumer; clinicians (oncologists, surgeons, pathologists) reached via a clinical liaison network and the SpeciCare Cancer Tissue Management Network; and research organizations (pharmaceutical companies, biotech firms, contract research organizations, and academic laboratories) accessed through SpeciBank, a biospecimen licensing sub-brand.

The product architecture is platform-plus-modules. The core platform is tissue cryopreservation and storage using a proprietary SpeciKit collection kit shipped to the patient's surgical team, with specimens transported to an FDA-compliant cryogenic facility at 690 Medical Park Ln, Gainesville, GA. Built atop this core are advanced testing modules including ex-vivo drug sensitivity testing (against 300+ therapies), genomic profiling (DNA/RNA sequencing), immunotherapy biomarker analysis (PD-L1, MMR/MSI, TMB), personalized vaccine pathway support, clinical trial matching, and organoid creation. SpeciBank operates as a separate sub-brand licensing cryopreserved biospecimens under MTAs to research customers, with a searchable database of 498+ entries.

Revenue is generated through four streams: one-time cryopreservation fees of $879 (tissue or bone marrow) or $1,499 (tissue + blood) plus shipping of $149-$499; recurring storage subscriptions at $29/month or $290/year; biospecimen licensing fees via SpeciBank (cost-recovery, study-based, programmatic, and derived-material access); and professional services fees for advanced testing coordination. Go-to-market combines DTC patient acquisition (free 15-minute consultations, Calendly booking, online/phone enrollment) with enterprise sales to clinicians and research institutions. The company has disclosed two funding rounds totaling approximately $3.6M (2016 and 2017) and operates with a lean leadership team of roughly 9-10 named staff.

Short descriptiontext

SpeciCare is a US healthcare company that cryopreserves live tumor tissue at -196°C and offers related advanced cancer testing, serving individual cancer patients, clinicians, and research organizations through direct and channel-based sales.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersGainesville, United States
HQ citystring
Gainesville
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
tissue cryopreservation services, cancer biospecimen storage, precision oncology testing, clinical trial biospecimens, cryopreserved tumor samples
Industry1 code
PRIMARYHLAGAIAJ
Sample Preparation, Storage & Cryogenics (Freezers, Cryovials, Cryostats)
NAICS code2 codes
  • Blood and Organ Banks621991
  • Research and Development in Biotechnology (except Nanobiotechnology)541714
SIC code2 codes
  • Services-Medical Laboratories8071
  • Services-Commercial Physical & Biological Research8731
Product category
Cancer Tissue Cryopreservation Services
GTM motion3 records

Each record includes

Type, Description, Source

Revenue model4 records
1Tissue Cryopreservation Services
TypeOne Time License
Description

One-time fees for cryopreservation of tumor tissue, blood, or bone marrow aspirate using proprietary SpeciKit collection system. Pricing varies by specimen type (tissue only, tissue and blood, or bone marrow). Includes processing and documentation.

specicare.com
2Cryostorage Services
TypeSubscription Recurring
Description

Recurring monthly or annual storage fees for maintaining cryopreserved biospecimens at ultra-low temperatures in FDA-compliant facility. Monthly autopay at $29/month or annual prepayment at $290/year (10 months of storage with 2 months free). Storage includes 4 aliquots; additional aliquots at $5 each.

specicare.com
3Biospecimen Licensing (SpeciBank)
TypeLicensing Royalties
Description

Governed access fees for research organizations, pharmaceutical companies, biotech innovators, and university laboratories to license cryopreserved cancer tissue samples. Includes cost-recovery access fees, study-based access, programmatic partnerships, and derived-material access. MTAs and standard contracting mechanisms used.

specicare.com
4Advanced Testing Coordination
TypeProfessional Services
Description

Coordination services for advanced testing including treatment effectiveness testing, genomic profiling, immunotherapy biomarker testing, and clinical trial matching. Testing priced separately based on which tests are selected.

specicare.com
Marketing channels10 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales
Pricing details8 tiers
1Tissue Cryopreservation
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$879 + S&H for cryopreservation of tissue or blood. Includes collection, processing, and initial preservation using SpeciKit system.

specicare.com
2Tissue AND Blood Cryopreservation
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$1,499 + S&H for cryopreservation of both tissue and blood specimens together.

specicare.com
3Bone Marrow Aspirate Cryopreservation
ModelOne time/ perpetual licenseBilling cadencePay-as-you-go
Notes

$879 + S&H for bone marrow aspirate cryopreservation.

specicare.com
4Monthly Storage (4 aliquots)
ModelSubscriptionBilling cadenceMonthly
Notes

$29/month using autopay. Includes storage of up to 4 aliquots of biospecimen.

specicare.com
5Annual Storage (4 aliquots)
ModelSubscriptionBilling cadenceAnnual
Notes

$290/year (10 months of storage, 2 months free). Savings of $58 compared to monthly billing.

specicare.com
6Additional Aliquots
ModelUnit PricingBilling cadencePay-as-you-go
Notes

$5 per additional aliquot after the first 4 included aliquots.

specicare.com
7Standard Shipping
ModelOtherBilling cadencePay-as-you-go
Notes

$149 for shipping & handling with 4+ days lead time.

specicare.com
8Expedited Shipping
ModelOtherBilling cadencePay-as-you-go
Notes

$499 for shipping & handling with 3 or fewer days lead time. Payment in full required prior to shipping SpeciKit.

specicare.com
GTM typeB2B and B2C
B2B and B2C
Offering typeServices
Services
Brand1 record
1SpeciBank
Description

A biospecimen licensing service providing high-quality cancer tissue samples to research organizations, pharmaceutical companies, biotech innovators, and university research laboratories for oncology research, drug development, biomarker discovery, and translational medicine.

specicare.com
Core offering1 text field

SpeciCare provides cryopreservation of live tumor tissue, blood, and bone marrow aspirate at -196°C in liquid nitrogen using its proprietary SpeciKit collection system, maintaining cellular viability and DNA/RNA integrity for decades. On this foundation, the company offers advanced testing coordination including ex-vivo drug sensitivity testing against 300+ therapies, genomic profiling, immunotherapy biomarker analysis, personalized vaccine pathway support, and clinical trial matching. Through its SpeciBank sub-brand, SpeciCare also licenses cryopreserved biospecimens to pharmaceutical companies, contract research organizations, biotech firms, and academic research laboratories for drug development and biomarker discovery.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Cryopreserved tissue enables testing against 300+ cancer drugs in ex-vivo sensitivity assays, while standard FFPE tissue cannot support any functional testing
+3 more records
Product overview1 text field

SpeciCare is a cancer tissue cryopreservation and advanced testing services company built on a platform-plus-modules architecture. The core platform is the Tissue Cryopreservation & Storage service, which preserves live tumor tissue at -196°C in liquid nitrogen to maintain cellular viability for future testing. Built on this foundation are advanced testing modules including Treatment Effectiveness Testing (ex-vivo drug sensitivity against 300+ therapies), Genomic Profiling (DNA/RNA sequencing for actionable mutations), Immunotherapy Readiness (biomarker evaluation including PD-L1, MMR/MSI, TMB), Personalized Vaccines (neoantigen-based vaccine pathway support), Clinical Trials Matching, and Organoid Creation (3D tumor model cultivation). The SpeciCare Cancer Tissue Management Network provides clinician-facing infrastructure for workflow standardization and research participation. SpeciBank enables research organizations to license biospecimens. The SpeciKit is a collection kit product for surgical team tissue handling.

Product and service2 records
1Tissue Cryopreservation & Storage
CategoryCancer tissue cryopreservation and storage
Description

Preservation of live tumor tissue, blood, and bone marrow aspirate at ultra-low temperatures (liquid nitrogen at -196°C) for long-term storage, maintaining cellular viability and molecular integrity for future testing, treatment decisions, and clinical trial access. One-time fees range from $879 to $1,499 plus shipping, with recurring storage at $29/month or $290/year.

2SpeciKit Collection System
Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Champions Oncology provides patient-derived xenograft (PDX) tumor models, ex-vivo drug screening, and biospecimen services for oncology research — directly comparable to SpeciCare's SpeciBank biospecimen licensing and ex-vivo drug sensitivity testing offering.

TypeDirect peer
Description

Crown Bioscience is a global preclinical CRO offering patient-derived models, biospecimens, and ex-vivo/in-vivo drug response assays — overlapping SpeciCare's research-side value proposition and serving the same pharma/biotech translational customers.

TypeDirect peer
Description

BioIVT supplies high-quality human biospecimens, including fresh and cryopreserved tissue, to pharmaceutical and academic researchers — a directly analogous biospecimen-licensing business to SpeciBank.

TypeDirect peer
Description

iSpecimen operates an online marketplace connecting researchers with human biospecimens from a network of healthcare providers — a comparable model for sourcing and licensing annotated tissue samples to pharma and academic customers.

TypeDirect peer
Description

Cureline is a human biospecimen provider offering fresh, frozen, and FFPE tissue with clinical data to life-science researchers — a directly comparable biospecimen supplier competing for the same SpeciBank customer base.

TypeDirect peer
Description

Folio Bio provides human tissue samples and biobanking services to pharmaceutical and academic researchers, including cryopreserved specimens with annotated clinical data — a directly comparable biospecimen CRO.

7Tempus
TypeBroad incumbent
Description

Tempus operates a precision medicine platform combining molecular profiling, biobanking, and AI-driven clinical decision support — overlapping SpeciCare's genomic profiling and clinical-trial matching modules but at vastly larger scale with broader data products.

TypeBroad incumbent
Description

Caris provides molecular profiling and biobanking services across cancer, including tissue-based NGS, with an established pharma research services arm — a broader incumbent operating in adjacent precision-oncology tissue services.

TypeEmerging player
Description

Personalis provides tumor-informed genomic profiling including whole-genome and RNA-based assays for oncology — comparable to SpeciCare's genomic profiling module but focused on the molecular analytics layer rather than cryopreservation.

10Tissue Solutions
TypeDirect peer
Description

Tissue Solutions supplies human tissue samples (fresh, frozen, FFPE) and biofluids to pharma and academic researchers with governed MTAs — a closely analogous biospecimen supplier to SpeciBank, primarily operating in Europe.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers5 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles9 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

SpeciCare

Cancer Tissue Cryopreservation Servicesspecicare.com

SpeciCare is a US healthcare company that cryopreserves live tumor tissue at -196°C and offers related advanced cancer testing, serving individual cancer patients, clinicians, and research organizations through direct and channel-based sales.

What SpeciCare does

SpeciCare is a privately held US healthcare services company founded in 2015 and headquartered in Gainesville, Georgia, that cryopreserves live tumor tissue at ultra-low temperatures (-196°C in liquid nitrogen) and offers a suite of advanced cancer testing services built on the preserved tissue. The company serves three customer segments: individual cancer patients acquired direct-to-consumer; clinicians (oncologists, surgeons, pathologists) reached via a clinical liaison network and the SpeciCare Cancer Tissue Management Network; and research organizations (pharmaceutical companies, biotech firms, contract research organizations, and academic laboratories) accessed through SpeciBank, a biospecimen licensing sub-brand.

The product architecture is platform-plus-modules. The core platform is tissue cryopreservation and storage using a proprietary SpeciKit collection kit shipped to the patient's surgical team, with specimens transported to an FDA-compliant cryogenic facility at 690 Medical Park Ln, Gainesville, GA. Built atop this core are advanced testing modules including ex-vivo drug sensitivity testing (against 300+ therapies), genomic profiling (DNA/RNA sequencing), immunotherapy biomarker analysis (PD-L1, MMR/MSI, TMB), personalized vaccine pathway support, clinical trial matching, and organoid creation. SpeciBank operates as a separate sub-brand licensing cryopreserved biospecimens under MTAs to research customers, with a searchable database of 498+ entries.

Revenue is generated through four streams: one-time cryopreservation fees of $879 (tissue or bone marrow) or $1,499 (tissue + blood) plus shipping of $149-$499; recurring storage subscriptions at $29/month or $290/year; biospecimen licensing fees via SpeciBank (cost-recovery, study-based, programmatic, and derived-material access); and professional services fees for advanced testing coordination. Go-to-market combines DTC patient acquisition (free 15-minute consultations, Calendly booking, online/phone enrollment) with enterprise sales to clinicians and research institutions. The company has disclosed two funding rounds totaling approximately $3.6M (2016 and 2017) and operates with a lean leadership team of roughly 9-10 named staff.

SpeciCare firmographics

Firmographics
Name
SpeciCare
Legal name
SpeciCare
Website
https://specicare.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
11–50 employees
Short description
SpeciCare is a US healthcare company that cryopreserves live tumor tissue at -196°C and offers related advanced cancer testing, serving individual cancer patients, clinicians, and research organizations through direct and channel-based sales.
Ownership category
akta.pro rank

SpeciCare industry classification

Industry
Product category
Cancer Tissue Cryopreservation Services
NAICS
Blood and Organ Banks (621991), Research and Development in Biotechnology (except Nanobiotechnology) (541714)
SIC
Services-Medical Laboratories (8071), Services-Commercial Physical & Biological Research (8731)
akta.pro industry
PRIMARYHLAGAIAJ
Sample Preparation, Storage & Cryogenics (Freezers, Cryovials, Cryostats)

Keywords

  • Tissue cryopreservation services
  • Cancer biospecimen storage
  • Precision oncology testing
  • Clinical trial biospecimens
  • Cryopreserved tumor samples

Where SpeciCare is headquartered

Location

Headquarters

HQ city
Gainesville
HQ country
United States
HQ region
North America

Offices2 records

Markets served

SpeciCare business model

Business model
GTM type
B2B and B2C
Offering type
Services
Cost components
Personnel, Operations, Infrastructure, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

  1. Tissue Cryopreservation Services: One-time fees for cryopreservation of tumor tissue, blood, or bone marrow aspirate using proprietary SpeciKit collection system. Pricing varies by specimen type (tissue only, tissue and blood, or bone marrow). Includes processing and documentation.
  2. Cryostorage Services: Recurring monthly or annual storage fees for maintaining cryopreserved biospecimens at ultra-low temperatures in FDA-compliant facility. Monthly autopay at $29/month or annual prepayment at $290/year (10 months of storage with 2 months free). Storage includes 4 aliquots; additional aliquots at $5 each.
  3. Biospecimen Licensing (SpeciBank): Governed access fees for research organizations, pharmaceutical companies, biotech innovators, and university laboratories to license cryopreserved cancer tissue samples. Includes cost-recovery access fees, study-based access, programmatic partnerships, and derived-material access. MTAs and standard contracting mechanisms used.
  4. Advanced Testing Coordination: Coordination services for advanced testing including treatment effectiveness testing, genomic profiling, immunotherapy biomarker testing, and clinical trial matching. Testing priced separately based on which tests are selected.

Pricing tiers

ModelBillingPrice
One time/ perpetual licensePay-as-you-goTissue Cryopreservation
One time/ perpetual licensePay-as-you-goTissue AND Blood Cryopreservation
One time/ perpetual licensePay-as-you-goBone Marrow Aspirate Cryopreservation
SubscriptionMonthlyMonthly Storage (4 aliquots)
SubscriptionAnnualAnnual Storage (4 aliquots)
Unit PricingPay-as-you-goAdditional Aliquots
OtherPay-as-you-goStandard Shipping
OtherPay-as-you-goExpedited Shipping

Go-to-market motion3 records

Distribution channels4 records

Marketing channels10 records

SpeciCare product offering

Product offering

Core offering

SpeciCare provides cryopreservation of live tumor tissue, blood, and bone marrow aspirate at -196°C in liquid nitrogen using its proprietary SpeciKit collection system, maintaining cellular viability and DNA/RNA integrity for decades. On this foundation, the company offers advanced testing coordination including ex-vivo drug sensitivity testing against 300+ therapies, genomic profiling, immunotherapy biomarker analysis, personalized vaccine pathway support, and clinical trial matching. Through its SpeciBank sub-brand, SpeciCare also licenses cryopreserved biospecimens to pharmaceutical companies, contract research organizations, biotech firms, and academic research laboratories for drug development and biomarker discovery.

Product overview

SpeciCare is a cancer tissue cryopreservation and advanced testing services company built on a platform-plus-modules architecture. The core platform is the Tissue Cryopreservation & Storage service, which preserves live tumor tissue at -196°C in liquid nitrogen to maintain cellular viability for future testing. Built on this foundation are advanced testing modules including Treatment Effectiveness Testing (ex-vivo drug sensitivity against 300+ therapies), Genomic Profiling (DNA/RNA sequencing for actionable mutations), Immunotherapy Readiness (biomarker evaluation including PD-L1, MMR/MSI, TMB), Personalized Vaccines (neoantigen-based vaccine pathway support), Clinical Trials Matching, and Organoid Creation (3D tumor model cultivation). The SpeciCare Cancer Tissue Management Network provides clinician-facing infrastructure for workflow standardization and research participation. SpeciBank enables research organizations to license biospecimens. The SpeciKit is a collection kit product for surgical team tissue handling.

Differentiator

Problem solved

Functional benefit

Brands

  • SpeciBank: A biospecimen licensing service providing high-quality cancer tissue samples to research organizations, pharmaceutical companies, biotech innovators, and university research laboratories for oncology research, drug development, biomarker discovery, and translational medicine.

Products and services

  • Tissue Cryopreservation & Storage Preservation of live tumor tissue, blood, and bone marrow aspirate at ultra-low temperatures (liquid nitrogen at -196°C) for long-term storage, maintaining cellular viability and molecular integrity for future testing, treatment decisions, and clinical trial access. One-time fees range from $879 to $1,499 plus shipping, with recurring storage at $29/month or $290/year.
  • SpeciKit Collection System

Quantifiable outcome

  • Cryopreserved tissue enables testing against 300+ cancer drugs in ex-vivo sensitivity assays, while standard FFPE tissue cannot support any functional testing
  • +3 more outcomes

Companies that use SpeciCare

Customer profile

Named customers5 records

Segments4 records

Ideal customer profiles3 records

SpeciCare technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

SpeciCare partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves6 records

Expansion highlights6 records

SpeciCare competitors and assessment

Company assessment

Direct peers

  • Champions Oncology: Champions Oncology provides patient-derived xenograft (PDX) tumor models, ex-vivo drug screening, and biospecimen services for oncology research — directly comparable to SpeciCare's SpeciBank biospecimen licensing and ex-vivo drug sensitivity testing offering.
  • Crown Bioscience (JSR Life Sciences): Crown Bioscience is a global preclinical CRO offering patient-derived models, biospecimens, and ex-vivo/in-vivo drug response assays — overlapping SpeciCare's research-side value proposition and serving the same pharma/biotech translational customers.
  • BioIVT: BioIVT supplies high-quality human biospecimens, including fresh and cryopreserved tissue, to pharmaceutical and academic researchers — a directly analogous biospecimen-licensing business to SpeciBank.
  • iSpecimen: iSpecimen operates an online marketplace connecting researchers with human biospecimens from a network of healthcare providers — a comparable model for sourcing and licensing annotated tissue samples to pharma and academic customers.
  • Cureline: Cureline is a human biospecimen provider offering fresh, frozen, and FFPE tissue with clinical data to life-science researchers — a directly comparable biospecimen supplier competing for the same SpeciBank customer base.
  • Folio Bio (formerly Conversant Bio): Folio Bio provides human tissue samples and biobanking services to pharmaceutical and academic researchers, including cryopreserved specimens with annotated clinical data — a directly comparable biospecimen CRO.
  • Tissue Solutions: Tissue Solutions supplies human tissue samples (fresh, frozen, FFPE) and biofluids to pharma and academic researchers with governed MTAs — a closely analogous biospecimen supplier to SpeciBank, primarily operating in Europe.

Broad incumbents

  • Tempus: Tempus operates a precision medicine platform combining molecular profiling, biobanking, and AI-driven clinical decision support — overlapping SpeciCare's genomic profiling and clinical-trial matching modules but at vastly larger scale with broader data products.
  • Caris Life Sciences: Caris provides molecular profiling and biobanking services across cancer, including tissue-based NGS, with an established pharma research services arm — a broader incumbent operating in adjacent precision-oncology tissue services.

Emerging players

  • Personalis: Personalis provides tumor-informed genomic profiling including whole-genome and RNA-based assays for oncology — comparable to SpeciCare's genomic profiling module but focused on the molecular analytics layer rather than cryopreservation.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks7 records

Key highlights7 records

Customer concentration

SpeciCare social profiles

Digital presence

SpeciCare financial estimates

Financial estimate

Revenue estimate

Valuation estimate

SpeciCare leadership team

Management profile

Number of profiles

Profiles9 records

SpeciCare funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

SpeciCare M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SpeciCare

What does SpeciCare do?

SpeciCare provides cryopreservation of live tumor tissue, blood, and bone marrow aspirate at -196°C in liquid nitrogen using its proprietary SpeciKit collection system, maintaining cellular viability and DNA/RNA integrity for decades. On this foundation, the company offers advanced testing coordination including ex-vivo drug sensitivity testing against 300+ therapies, genomic profiling, immunotherapy biomarker analysis, personalized vaccine pathway support, and clinical trial matching. Through its SpeciBank sub-brand, SpeciCare also licenses cryopreserved biospecimens to pharmaceutical companies, contract research organizations, biotech firms, and academic research laboratories for drug development and biomarker discovery.

Is SpeciCare a public or private company?

SpeciCare is a private company. It is classified as venture growth investor backed and is currently operating.

When was SpeciCare founded?

SpeciCare was founded in 2015. It employs 11 to 50 people.

Where is SpeciCare based?

SpeciCare is headquartered in Gainesville, United States, in the North America region.

How does SpeciCare make money?

Four revenue lines are on record. Tissue Cryopreservation Services are the primary driver. The others are cryostorage Services, biospecimen Licensing (SpeciBank) and advanced Testing Coordination.

Who are SpeciCare's main competitors?

Direct peers on record are Champions Oncology, Crown Bioscience (JSR Life Sciences), BioIVT, iSpecimen, Cureline, Folio Bio (formerly Conversant Bio) and Tissue Solutions. Broad incumbents are Tempus and Caris Life Sciences. Personalis is listed as an emerging player.

Does SpeciCare have an API?

No public API is recorded for SpeciCare.

What industry is SpeciCare in?

SpeciCare's product category is Cancer Tissue Cryopreservation Services. Its primary akta.pro industry code is HLAGAIAJ, Sample Preparation, Storage & Cryogenics (Freezers, Cryovials, Cryostats). Its NAICS code is 621991 and its SIC code is 8071.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
EIN PresswireSpeciCare Releases 'Before the Biopsy,' a New Patient Guide to Biopsy Tissue PreservationSpeciCare released a free patient guide titled 'Before the Biopsy' explaining biopsy tissue preservation options. The guide contrasts FFPE with cryopreservation and lists questions patients should ask before procedures. It is available at specicare.com/ebook.EIN PresswireNew Peer-Reviewed Research Shows That Tissue Preservation Significantly Impacts the Future Utility of Precision OncologyA peer-reviewed study from SpeciCare researchers found that formalin-fixed, paraffin-embedded (FFPE) tissue preservation can damage DNA, leading to sequencing failures in 20-40% of samples and only 43.5% variant overlap with cryopreserved tissue. The paper argues cryopreservation better preserves low-variant allele frequency mutations, which may affect drug resistance and recurrence detection.SpecicareSpeciCare – Cancer Biopsy Tissue CryopreservationSpecicare offers cryopreservation of cancer biopsy tissue at -196°C to preserve viable cells for advanced testing and clinical trials. The service costs $3,999 for cryopreservation, $69 per month for storage, and $599 for shipping, with advanced testing priced separately. It claims to expand access to precision treatments and trials that require living tissue.PR NewswireCancer Surgeon Fueled by a Passion to Do More Launches SpeciCare to Store Live Tumor Tissue for Personalized Use in Cancer CareDr. Ken Dixon launched SpeciCare, a new service in Gainesville, Georgia, designed to collect and store live patient tumor tissue for personalized cancer care and research. The initiative aims to bridge the gap between community-based treatment and advanced precision medicine by enabling access to individualized clinical trials and therapies.